A nurse is caring for a client who has oligohydramnios and is undergoing a biophysical profile (BPP).

The nurse should expect to see which of the following findings on the ultrasound?

Choice A is wrong because it describes a transabdominal CVS procedure, which involves a needle instead of a catheter.

Choice C is wrong because it describes a procedure that is not used for CVS.A needle inserted through the cervix could damage the fetal membranes or cause bleeding.

Choice D is wrong because it describes a procedure that is not possible.A catheter cannot be inserted through the abdomen and uterus into the placenta.

Normal ranges for CVS are not applicable as it is a diagnostic test, not a screening test.

It provides a definitive result of whether the fetus has a chromosomal abnormality or a genetic disorder.CVS is usually done between 10 and 13+6 weeks of pregnancy.

AFP is a screening tool that can indicate the possibility of certain fetal anomalies, such as neural tube defects, abdominal wall defects, or chromosomal abnormalities.

However, AFP results are not diagnostic and cannot confirm the presence or absence of these conditions.

Therefore, further tests, such as ultrasound or amniocentesis, are needed to verify the results.

Choice A is wrong because AFP results are not diagnostic for fetal anomalies.

They only indicate a risk level that needs to be confirmed by other tests.

Choice C is wrong because AFP results can detect not only neural tube defects, but also other fetal anomalies, such as abdominal wall defects or chromosomal abnormalities.

Choice D is wrong because AFP results are not affected by maternal race and ethnicity.

They are affected by maternal age, weight, diabetes, multiple gestation, and gestational age.